Medicamen Biotech Ltd.

MEDICAMEQ

₹344.05

-0.68% (-2.35)

Market Cap

₹467 Cr.

P/E

49.17

Key Ratios

Edit Ratio's

Market cap

467 Cr

49.17

Prom Holding

40.46 %

ROE (%)

4.59

ROCE (%)

9.04

Div Yield (%)

0.58

Sales

162 Cr

OPM (%)

9.25 %

Debt to Equity

0.16

Edit Ratio's

About

Medicamen Biotech Limited is a pharmaceutical company engaged in manufacturing and marketing p… Read more

Low

340

52W Range

High

630

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Medicamen Biotech Ltd. Business

What does Medicamen Biotech do?

Medicamen Biotech Limited is a pharmaceutical company that manufactures and markets a variety of pharmaceutical formulations globally. Its product range includes tablets, capsules, liquid syrups, and dry syrups.

Who are the competitors of Medicamen Biotech?

Medicamen Biotech major competitors are Jenburkt Pharma, Albert David, Brooks Laboratories, Zim Laboratories, Lyka Labs, Fredun Pharma, Venus Remedies.
Market Cap of Medicamen Biotech is ₹472 Crs.
While the median market cap of its peers are ₹459 Crs.

Is Medicamen Biotech financially stable compared to its competitors?

Medicamen Biotech seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation		Sep		Mar Sep Dec	Sep	Mar Jun Sep		Jun	Jun Sep
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Medicamen Biotech Ltd.

Medicamen Biotech Ltd.

Key Ratios

About

Timeline

Company Timeline

5 Yes

2 Neutral

9 No

1 No Data

Accounting & Shareholding

Other Income

Pledge

Revenue Recognition

Depreciation Effect

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

ROE

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Debt

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

What does Medicamen Biotech do?

Who are the competitors of Medicamen Biotech?

Is Medicamen Biotech financially stable compared to its competitors?

Medicamen Biotech Ltd.

Medicamen Biotech Ltd.

Key Ratios

About

Timeline

Company Timeline

5 Yes

2 Neutral

9 No

1 No Data

Accounting & Shareholding

Other Income

Pledge

Revenue Recognition

Depreciation Effect

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

ROE

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Debt

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

What does Medicamen Biotech do?

Who are the competitors of Medicamen Biotech?

Is Medicamen Biotech financially stable compared to its competitors?

SIGN UP FOR FREE